Cocaine Use Disorder Market Set to Cross $2 Billion by 2030: Global Trends, Analysis and Forecasts by Therapeutic Approach, Medication, Treatment Setting and Region with Profiles on Key Players

Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Global Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Forecast 2024-2030" report has been added to's offering.

The Cocaine Use Disorder Market was estimated at USD 1.32 billion in 2023, USD 1.39 billion in 2024, and is expected to grow at a CAGR of 6.21% to reach USD 2.01 billion by 2030.

The increased awareness and social acceptance of addiction issues are necessitating the treatments for cocaine use disorders. The governmental and private funding for addiction treatment programs influences the market scope. The advancements in treatment methodologies and the growing prevalence of cocaine use worldwide are also enhancing the adoption of cocaine use disorder treatments.

However, the limited availability of specialized healthcare providers and social stigmas associated with drug addiction may limit the adoption of treatment options. Regulatory hurdles and variability in treatment effectiveness across populations also pose significant challenges for market growth.

Moreover, personalized medicine approaches utilizing genetic and psychosocial markers to tailor treatments generate significant growth potential. The application of artificial intelligence and machine learning in predicting treatment outcomes and enhancing patient engagement through digital platforms also creates significant opportunities for market expansion.

Regional Insights

In the Americas region, cocaine remains a significant public health concern, with considerable investments into research on novel treatments and rehabilitation programs. The demand for effective treatment options underscores the urgent consumer need for support in managing cocaine use disorder in the United States and Canada. Recent patents in the Americas region have highlighted innovative therapeutic approaches, including pharmacological interventions and digital health solutions designed to curb addiction.

The European Union countries demonstrate a varied spectrum of cocaine use patterns, from high prevalence rates in nightlife settings to more contained use in broader populations. Significant efforts are being made to unify data collection and reporting standards across the EMEA region to better address consumer needs. Initiatives to tackle cocaine use are in nascent stages in the Middle East and Africa region, often integrated within broader drug misuse prevention programs.

In the APAC region, Major countries such as China, India, and Japan enacted strict drug enforcement policies and are investing in public education campaigns to deter substance use. Research into the nature of drug addiction and its treatment is growing in APAC countries, reflecting a burgeoning awareness of the need for evidence-based interventions in the management of cocaine use disorder.

Market Segmentation Analysis

  • Treatment Setting: Increasing preference for residential rehabilitation facilities
  • Medications: Need-based preference for psychostimulants for treatment of cocaine use disorder

Industry Insights

  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cocaine Use Disorder Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cocaine Use Disorder Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

  • Scientists Develop a Vaccine for Cocaine
  • FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cocaine Use Disorder Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include:

  • Alkermes PLC
  • Alnylam Pharmaceuticals, Inc.
  • Camurus AB
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • KemPharm, Inc.
  • Novartis International AG
  • Orexo AB
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Revive Therapeutics Ltd.
  • Sage Therapeutics, Inc.
  • Shionogi & Co. Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Cocaine Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapeutic Approaches

  • Behavioral Therapies
  • Cognitive-Behavioral Therapy
  • Contingency Management
  • Medication-Assisted Treatment
  • Motivational Enhancement


  • Anticonvulsants
  • Antidepressants
  • Antipsychotics
  • Psychostimulants

Treatment Setting

  • Hospital-Based Treatment Programs
  • Inpatient Rehabilitation Centers
  • Outpatient Rehabilitation Centers
  • Residential Rehabilitation Facilities


  • Americas
  • Asia-Pacific
  • Europe, Middle East & Africa

Key Attributes

Report AttributeDetails
No. of Pages198
Forecast Period2024-2030
Estimated Market Value (USD) in 2024$1.39 Billion
Forecasted Market Value (USD) by 2030$2.01 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Cocaine Use Disorder Market

Contact Data